Merck & Co.
AWARDS
NEWS
Keytruda (pembrolizumab) hit one of the coprimary endpoints early in the Phase III KEYNOTE-177 clinical trial for a highly mutating form of colorectal cancer.
As COVID-19 continues to expand across the globe, more pharmaceutical companies are hitting the brakes on clinical trials as part of an effort to ease the burden on doctors and facilities needed to treat patients combating the disease.
A summary of daily biopharma industry news. Please check out stories that are trending on March 27, 2020.
A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.
The U.S. National Institutes of Health announced that a Phase II clinical trial of AstraZeneca and Merck’s selumetinib in neurofibromatosis type 1 shrank inoperable tumors.
Restricting face-to-face interactions with people will go a long way in limiting the spread of the virus.
JOBS
IN THE PRESS